Smart pump learns your workout routine to stop dangerous sugar drops

NCT ID NCT03859401

Completed Disease control Sponsor: Marc Breton Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an artificial pancreas system that learns a person's exercise patterns to prevent low blood sugar (hypoglycemia) during and after moderate exercise. Fifteen adults with type 1 diabetes used the system for about 4 months, comparing it to a standard version. The goal was to see if the smart system could reduce dangerous low blood sugar episodes around exercise time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: artificial pancreas system (EnMPC controller)
What this could lead to: If it works, this could help people with type 1 diabetes exercise more safely with fewer dangerous low blood sugar episodes.
What could go wrong: This was a very small, early-stage trial with only 15 participants. The system may not work for everyone or in real-world conditions outside the clinic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity type 1 diabetes mellitus hypoglycemia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOGLYCEMIA TYPE 1 DIABETES MELLITUS

Contacts and locations

Locations

University of Virginia

Charlottesville, Virginia, 22908, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.